Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Cash: 2018-2025

Historic Change in Cash for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to $12.2 million.

  • Neurogene's Change in Cash rose 127.46% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 79.58%. This contributed to the annual value of -$11.8 million for FY2024, which is 117.68% down from last year.
  • As of Q3 2025, Neurogene's Change in Cash stood at $12.2 million, which was up 201.96% from -$12.0 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Change in Cash peaked at $103.2 million during Q4 2023, and registered a low of -$65.8 million during Q1 2025.
  • In the last 3 years, Neurogene's Change in Cash had a median value of -$12.0 million in 2025 and averaged -$970,636.
  • Examining YoY changes over the last 5 years, Neurogene's Change in Cash showed a top increase of 127.46% in 2025 and a maximum decrease of 3,837.37% in 2025.
  • Over the past 3 years, Neurogene's Change in Cash (Quarterly) stood at $103.2 million in 2023, then tumbled by 32.19% to $70.0 million in 2024, then soared by 127.46% to $12.2 million in 2025.
  • Its Change in Cash was $12.2 million in Q3 2025, compared to -$12.0 million in Q2 2025 and -$65.8 million in Q1 2025.